Igenbio, Inc. announced today the addition of ‘ERGO Workflows’, a suite of automated analysis pipelines that transforms raw sequence data into actionable results. “Bioinformatics tools are typically command line Linux programs requiring intensive computer resources. This presents a major barrier to starting research. Igenbio’s aim is to make the best analysis tools available to every researcher. That’s why we’re so excited to announce ERGO Workflows, because it brings us closer than ever to that goal,” says Vinayak Kapatral, President CEO of Igenbio, Inc.Read More
CHICAGO--(BUSINESS WIRE)--Igenbio, Inc. announced today the expansion of variant analysis service offerings. Igenbio’s comprehensive variant analysis service answers pressing questions in genome differences reflecting changes to metabolic pathways and genetic associations relevant to disease- or cancer-causing variations. Igenbio’s flagship product ERGO 2.0 enables researchers to deepen the analysis of variations with interactive visualizations enabling industrial, academic, and medical scientists to rapidly uncover hidden genetic variations and develop diagnostic biomarkers.
“Research scientists can use ERGO’s Variant workflow by simply “dragging-and-dropping” the sequence files into ERGO and receiving scientifically rigorous results in minutes. Discover single nucleotide polymorphisms (SNPs), insertions, deletions (INDELS), along with their functional relevance and deleterious effects. ERGO does it all for you: from sequence quality assessments to annotating variant effects of any genome. This furthers our goal of making the best bioinformatics analysis available to all researchers, regardless of their computer experience.”, says Benjamin Vaisvil, VP, Bioinformatics and Software Development at Igenbio, Inc.
Chicago-based Igenbio, Inc. specializes in research in genomics, bioinformatics, and transcriptomics. Igenbio, Inc. serves a broad customer base across industry, academic and government institutions. ERGO 2.0 integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, with tools and workflows for common bioinformatics tasks. Our goal is to make the best scientific analysis available to all researchers.
February 13, 2018 04:27 PM Eastern Standard Time
CHICAGO--Igenbio, Inc. announced today the expansion of metagenomics service offerings to include microbial community profiling, and microbial community metabolic analysis. Igenbio’s microbial community analysis service helps answer pressing questions in microbiome, environmental, and clinical studies. Igenbio’s scientists’ expertise streamlines the development of custom assays which efficiently answer specific research questions. Analysis offerings range from rRNA analysis, to whole metagenome sequencing, and qPCR. Igenbio’s flagship product ERGO 2.0 enables researchers to deepen the analysis of expression data on interactive exportable metabolic pathway visualizations enabling industrial, academic, and medical scientists to rapidly discover and develop diagnostic biomarkers.
Igenbio, Inc., a genomics and informatics solutions provider, has expanded its metagenomics and metatranscriptomics offerings. ERGO provides scientists meaningful results of metagenomes and metatranscriptome and eliminates the complexity of meta data management.Read More
CHICAGO--Igenbio, Inc., a genomics and informatics solutions provider, has expanded its service offerings into the human genome analytics market. With its flagship cloud-based Software as a Service (SaaS) analytics platform ERGO, known in the microbial and synthetic biology spaces, Igenbio, Inc. now offers human genome RNA sequence analytics. ERGO provides fully featured coding and non-coding gene expression analytics for RNA-Seq. ERGO's human analytics module is easy to use and surpasses present desktop software offerings for computing differential gene expression, clustering, and variant detection. “ERGO frees scientists from the costly hassle of complex data and software management,” said Vinayak Kapatral Ph.D. President, CEO of Igenbio, Inc.Read More
Igenbio, Inc. announced today the release of ERGO 2.0, the latest version of a unique integrated platform that enables industrial, academic, and medical scientists to rapidly develop knowledge from existing and new DNA sequencing projects. ERGO 2.0 will help reduce time to market by saving precious lab effort and resources. ERGO 2.0 contains a massive curated database integrated with state of the art synthetic biology tools enabling faster product creation.Read More
October 29, 2014
Eurofins Genomics and Igenbio have announced a co-operation agreement to combine their expertise in sequencing and analysis services for microbial, fungal and algal organisms.
August 19, 2014
Igenbio, Inc., a Chicago based genome analysis company, announced today that they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company.
05/10/2011 Ebersberg, Germany and Mount Prospect, IL, USA
Eurofins MWG Operon and Integrated Genomics have announced a cooperation agreement to combine their expertise in sequencing and analysis services for microbial, fungal and algal organisms.Read More
Arlington Heights, IL (February 9, 2010) Integrated Genomics, Inc., a leader in microbial genomic informatics, is collaborating with Focus Ahead Consulting Ltd. in the UK to represent and market microbial genome sequencing and bioinformatics services in Europe. Integrated Genomics ERGO™ platform is the leading informatics system for microbial systems biology.Read More
CHICAGO, IL (May 5, 2009) – Integrated Genomics, Inc. today announces it has appointed Jose Laplaza, Ph.D. as Director of Strain Engineering and Lab Operations. Dr. Laplaza brings significant experience in gene expression, fermentation optimization and strain development. He will be responsible for leading IG’s efforts in contract and internal metabolic engineering research.Read More
(Chicago, IL and Guildford, UK) Integrated Genomics, Inc., a leader in microbial genomic informatics and TMO Renewables Limited, a leader in the production of ethanol from biomass, announced today that they have signed an agreement to extend their collaboration on the discovery of cellulosic bioethanol production systems.Read More
Chicago, Illinois. Integrated Genomics announced the publication of the complete Granulibacter bethesdensisgenome sequence, the first acetic acid bacteria to be identified as an agent of an emerging invasive human disease.Read More
Cincinnati, OH - Scientists from P&G Beauty announced that they successfully sequenced the complete genome for Malassezia globosa (M. globosa), a naturally occurring fungus responsible for the onset of dandruff and other skin conditions in humans. Results of the genome sequencing are published in the November fifth online edition of Proceedings of the National Academy of Sciences (PNAS).Read More
(Chicago IL, Beverly MA, and Wolfenbüttel Germany) Integrated Genomics Inc. and BIOBASE GmbH announced today that they have signed a collaboration agreement to expand and curate Integrated Genomics' ERGO™ microbial genomic database. BIOBASE scientists in Bangalore, India will add manually-curated functional gene annotations and pathways to the ERGO genomic database. This agreement further expands the custom curation services BIOBASE offers its customers.Read More
(Chicago, IL and Daejeon, South Korea) Korean research Institute of Bioscience and Biotechnology (KRIBB), a world leader in the integrated biotechnology and bioinformatics has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. KRIBB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes.Read More
(Chicago, IL and Guildford, UK) TMO Renewables Limited, a leader in the production of ethanol from biomass, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. TMO will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as comparative genomics.Read More
New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. NEB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes.Read More
CHICAGO, IL - March 14, 2007
Integrated Genomics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the US Environmental Protection Agency (EPA) to develop methods to improve the bio-production of butanol. Currently butanol is produced from petroleum feedstock.Read More